beta endorphin
Recently Published Documents


TOTAL DOCUMENTS

1252
(FIVE YEARS 39)

H-INDEX

67
(FIVE YEARS 2)

2022 ◽  
Vol 14 ◽  
Author(s):  
Fan Wang ◽  
Hui Li ◽  
Qingshuang Mu ◽  
Ligang Shan ◽  
Yimin Kang ◽  
...  

Objectives: Cigarette smoking is associated with postoperative pain perception, which might be mediated by beta-endorphin and substance P. These effects on postoperative pain perception have never been investigated in human cerebrospinal fluid (CSF), which reflects biochemical alterations in the brain. Therefore, we investigated the associations among cigarette smoking, postoperative pain, and levels of beta-endorphin and substance P in human CSF.Methods: We recruited 160 Chinese men (80 active smokers and 80 nonsmokers) who underwent lumbar puncture before anterior cruciate ligament reconstruction, and 5-ml CSF samples were collected. Pain visual analog scale (VAS) scores, post-anesthetic recovery duration (PARD), and smoking variables were obtained. CSF levels of beta-endorphin and substance P were measured.Results: Compared to non-smokers, active smokers had significantly higher pain VAS (2.40 ± 0.67 vs. 1.70 ± 0.86, p < 0.001) and PARD scores (9.13 ± 2.11 vs. 7.27 ± 1.35, p = 0.001), lower CSF beta-endorphin (33.76 ± 1.77 vs. 35.66 ± 2.20, p = 0.001) and higher CSF substance P (2,124.46 ± 217.34 vs. 1,817.65 ± 302.14, p < 0.001) levels. Pain VAS scores correlated with PARD in active smokers (r = 0.443, p = 0.001).Conclusions: Cigarette smoking is associated with increased postoperative pain intensity, shown by delayed pain perception, higher pain VAS scores, and lower beta-endorphin and higher substance P levels in the CSF of active smokers. The more extended postoperative pain perception is delayed, the more pain intensity increases.


Author(s):  
Diar Mia Ardani ◽  
Bakti Surarso ◽  
Nyilo Purnami ◽  
Rizka Fathoni Perdana

Abstract Introduction Nasopharyngeal carcinoma (NPC) is the most common malignancy in the field of otorhinolaryngology, and chronic pain is identical with this malignancy. Pain therapy according to World Health Organization (WHO) recommendations is WHO 3-step analgesic ladder. Pain is subjective and related to the function of beta-endorphin hormone. Objective Analyzing the relationship between the degree of pain and plasma endorphin levels in stage III–IV NPC patients before and after the administration of WHO 3-step analgesic ladder. Materials and Methods The study design used pretest and posttest without control design. Participants were given WHO 3-step analgesic ladder therapy for 3 days. The participants then rated the pain scale using the visual analog scale (VAS) and plasma beta-endorphin levels in venous blood. The statistical test used the dependent t-test, Wilcoxon test, and Spearman test with p < 0.05, confidence interval: 95%. Results There were 14 stage-III NPC patients with moderate pain (78.57%) and 31 stage-IV NPC participants had moderate pain (83.87%; p = 0.071). The VAS value in the moderate pain group before and after therapy was 82.22 and 66.67%, respectively (p < 0.001). The values of plasma beta-endorphin levels before and after therapy were 74.89 ± 69.12 and 72.49 ± 75.53 pg/mL, respectively (p = 0.647). Plasma beta-endorphin levels were −19.20 ± 37.72 pg/mL (mild pain), −4.76 ± 35.30 pg/mL (moderate pain), and −21.67 ± 6.27 pg/mL (severe pain; p = 0.717). Conclusion Pain levels in advanced NPC patients have decreased after the therapy, but plasma beta-endorphin levels have no significant difference.


2021 ◽  
Vol 15 ◽  
Author(s):  
Prableen K. Singh ◽  
Kabirullah Lutfy

Endogenous opioids have been implicated in cocaine reward. However, the role of each opioid peptide in this regard is unknown. Notably, the role of each peptide in extinction and reinstatement is not fully characterized. Thus, we assessed whether cocaine-induced conditioned place preference (CPP) and its extinction and reinstatement would be altered in the absence of beta-endorphin. We also examined if sex-related differences would exist in these processes. Male and female mice lacking beta-endorphin and their respective controls were tested for baseline place preference on day 1. On day 2, mice were treated with saline/cocaine (15 mg/kg) and confined to the vehicle- or drug-paired chamber for 30 min, respectively. In the afternoon, mice were treated with the alternate treatment and confined to the opposite chamber. Mice were then tested for CPP on day 3. Mice then received additional conditioning on this day as well as on day 4. Mice were then tested for CPP on day 5. Mice then received extinction training on day 9. On day 10, mice were tested for extinction and then reinstatement of CPP following a priming dose of cocaine (7.5 mg/kg). Male and female mice lacking beta-endorphin did not exhibit CPP following single conditioning with cocaine. On the other hand, only male mice lacking beta-endorphin failed to show CPP after repeated conditioning. Nonetheless, reinstatement of CPP was blunted in both male and female mice lacking beta-endorphin compared to controls. The present results suggest that beta-endorphin plays a functional role in cocaine-induced CPP and its reinstatement, and sex-related differences exist in the regulatory action of beta-endorphin on the acquisition but not reinstatement of cocaine CPP.


2021 ◽  
Vol 10 (23) ◽  
pp. 5696
Author(s):  
Olga V. Roschina ◽  
Lyudmila A. Levchuk ◽  
Anastasiia S. Boiko ◽  
Ekaterina V. Michalitskaya ◽  
Elena V. Epimakhova ◽  
...  

Background: The neuropeptides β-endorphin and oxytocin are released into the bloodstream as hormones from the pituitary gland but also have an important function as neuroregulators in the forebrain. The blood levels of both polypeptides have been shown to reflect depressive symptoms. β-Endorphin, in particular, is also involved in abstinence from alcohol. Methods: The serum levels of β-endorphin and oxytocin were measured during the early withdrawal phase in patients with alcohol use disorder (AUD) with (N = 35) or without (N = 45) depressive comorbidity and compared with those in healthy volunteers (N = 23). In addition to comparing the groups, the study examined whether serum levels correlated with various psychometric measures of dependence, depression and aggression, as well as with clinical characteristics of dependence. Results: Both serum levels of beta-endorphin and oxytocin were significantly lower in patients than those in healthy controls (p = 0.011 for β-endorphin and p = 0.005 for oxytocin, Kruskal–Wallis test). In patients with depressive comorbidity, the significance was greatest (p = 0.005 for β-endorphin and p = 0.004 for oxytocin, U-test). There was no correlation with clinical or psychometric parameters (p > 0.05, Spearman test), but beta-endorphin levels did correlate significantly with physical aggression (p = 0.026, Spearman test). Conclusions: Serum levels of β-endorphin and oxytocin are lower in patients with AUD, particularly in those with depressive comorbidity. β-Endorphin levels correlated with physical aggression according to the Buss–Durkee (BDHI) estimates.


2021 ◽  
Vol 25 (09) ◽  
pp. 352-352
Author(s):  
Dietmar Wiederhold

Patienten, die mit einer Hämodialyse behandelt werden, nehmen Schmerzen als die häufigste Nebenwirkung der Behandlung war. Schmerzen können die Schlafqualität, die emotionale Stimmung, die zwischenmenschlichen Beziehungen und die Lebensaktivitäten negativ beeinflussen sowie körper liche Einschränkungen verursachen. Ist die Schlafqualität vermindert, sind die Patienten durch eine wahrgenommene Energielosigkeit weniger in der Lage, ihren täglichen Aufgaben nachzugehen. Es wird beschrieben, dass Lachyoga die Atmung stärkt, Muskeln entspannt und durch die Ausschüttung von Endorphinen die Schmerztoleranz erhöht. Ebenso sollen kognitive Funktionen durch die Senkung von Stresshormonen verbessert, Ängste und depressive Stimmungen reduziert, die Schlafqualität erhöht und das psychische Wohlbefinden durch die Förderung zwischenmenschlicher Beziehungen und Interaktionen verbessert werden. Die vorliegende Studie untersucht die Wirksamkeit von Lachyoga auf den Beta-Endorphin-Spiegel, die Schmerzstärke und die Schlafqualität bei Hämodialysepatienten.


Author(s):  
Luke Hughes ◽  
Ian Grant ◽  
Stephen David Patterson

Aim: This study examined the effect of aerobic exercise with and without blood flow restriction on exercise-induced hypoalgesia and endogenous opioid and endocannabinoid systems. Methodology: In a randomised crossover design, pain-free individuals performed 20 min of cycling in four experimental trials: 1) Low intensity aerobic exercise (LI-AE) at 40% V̇O2max; 2) LI-AE with low pressure BFR (BFR40); 3) LI-AE with high pressure BFR (BFR80); and 4) High intensity aerobic exercise (HI-AE) 70% V̇O2max. Pressure pain thresholds (PPT) were assessed before and 5 min post-exercise. Circulating concentrations of beta-endorphin and 2-arachidonoylglycerol were assessed before and 10 min post-exercise. Results: In the exercising legs, post-exercise PPTs were increased following BFR40 and BFR80 compared to LI-AE (23-32% vs 1-2%, respectively). Post-exercise PPTs were comparable to HI-AE (17-20%) with BFR40 and greater with BFR80 (30-32%). Both BFR80 and HI-AE triggered comparable systemic hypoalgesia in remote areas of the body (26-28% vs 19-21%). Post-exercise circulating beta-endorphin concentration was increased following BFR40 (11%) and HI-AE (14%, with the greatest change observed following BFR80 (29%). Post-exercise circulating 2-arachidonoylglycerol concentration was increased following BFR40 (22%) and BFR80 (20%), with the greatest change observed following HI-AE (57%). Conclusion: Addition of BFR to LI-AE can trigger both local and systemic hypoalgesia that is not observed follow LI-AE alone and activate endogenous opioid and endocannabinoid systems of pain inhibition. Compared to HI-AE, local and systemic hypoalgesia following LI-AE with high pressure BFR is greater and comparable, respectively. LI-AE with BFR may help pain management in load compromised individuals.


Author(s):  
Ayse Ebru Abali ◽  
Tugrul Cabioglu ◽  
Nilufer Bayraktar ◽  
Binnaz Handan Ozdemir ◽  
Gokhan Moray ◽  
...  

Abstract Objectives We investigated acupuncture, a potential contributor for burn-care, on physiological and pathological pain mechanisms and systemic and local inflammatory responses in a rat experimental burn model. Methods Forty male Sprague-Dawley rats were divided into 2 groups. One-hour groups(5 rats/group) were observed for 1 hour and included Sh1(sham/observation), ShA1(sham+acupuncture/observation), Brn1(burn/observation), and BrnA1(burn+acupuncture/observation). Seven-day groups(5 rats/group) were observed for 7 days and included Sh7(sham/observation), ShA7(sham+acupuncture/observation), Brn7(burn/observation), and BrnA7(burn+acupuncture/observation). “Pain-distress scores” were noted daily, acupuncture was repeated within every wound-dressing change on alternate days. After observation periods, blood samples for interleukin-6 and beta-endorphin and skin biopsies for inflammatory-changes and immunohistochemical-staining of interleukin-6 were collected for analysis( P&lt; .05 ). Results In 1-hour groups, interleukin-6 accumulation in burn wounds of BrnA1 was less than Brn1, with Brn1 having the highest mean blood level(P&lt; .05). Mean beta-endorphin levels were higher in ShA1, Brn1, and BrnA1 than in Sh1(P&lt; .05). In all 7-day groups, the agonizing period was 48 to72 hours after burn, with Brn7 most affected(P&lt; .05). Microvessels were multiplied in Brn7group, with significantly higher numbers in burn wounds of BrnA7(P˂ .05). Burn wounds of BrnA7 had less accumulation of interleukin-6 than Brn7 with Brn7-group having the highest mean blood level and Sh7, ShA7, and BrnA7 having similarly low levels(P˃ .05). Beta-endorphin levels in ShA7, Brn7, and BrnA7 were lower than in Sh7(P&lt; .05). Conclusions Acupuncture contributed to management of physiological and pathological pain, modulation of inflammatory responses, and associated enhancement of angiogenesis in acute phase of burn injury in rats.


Biomolecules ◽  
2021 ◽  
Vol 11 (8) ◽  
pp. 1077
Author(s):  
Timothy J. Schoenfeld ◽  
Chance Swanson

Physical exercise has wide-ranging benefits to cognitive functioning and mental state, effects very closely resembling enhancements to hippocampal functioning. Hippocampal neurogenesis has been implicated in many of these mental benefits of exercise. However, precise mechanisms behind these effects are not well known. Released peripherally during exercise, beta-endorphins are an intriguing candidate for moderating increases in neurogenesis and the related behavioral benefits of exercise. Although historically ignored due to their peripheral release and status as a peptide hormone, this review highlights reasons for further exploring beta-endorphin as a key mediator of hippocampal neurogenesis. This includes possible routes for beta-endorphin signaling into the hippocampus during exercise, direct effects of beta-endorphin on cell proliferation and neurogenesis, and behavioral effects of manipulating endogenous opioid signaling. Together, beta-endorphin appears to be a promising mechanism for understanding the specific ways that exercise promotes adult neurogenesis specifically and brain health broadly.


Sign in / Sign up

Export Citation Format

Share Document